Nurix Therapeutics, Inc. (NRIX)

NASDAQ: NRIX · Real-Time Price · USD

22.71

-0.41 (-1.77%)

At close: Jul 20, 2026, 4:00 PM EDT

22.70

-0.01 (-0.04%)

Pre-market: Jul 21, 2026, 4:06 AM EDT

Nurix Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is December - November.

Millions USD. Fiscal year is Dec - Nov.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 31, 2026	Nov '25 Nov 30, 2025	Nov '24 Nov 30, 2024	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021
Cash & Equivalents	67.69	246.96	110	54.63	64.47	80.51
Short-Term Investments	375.84	345.98	499.59	233.28	244.67	215.21
Cash & Short-Term Investments	443.53	592.94	609.58	287.91	309.14	295.72
Cash Growth	-8.70%	-2.73%	111.73%	-6.87%	4.54%	5.18%
Accounts Receivable	-	-	-	-	-	6
Other Receivables	-	-	-	-	-	0.2
Total Trade Receivables	-	-	-	-	-	6.2
Other Current Assets	12.95	13.88	9.8	7.6	9.31	9.19
Total Current Assets	456.48	606.82	619.39	295.5	318.45	311.12
Net Property, Plant & Equipment	70.11	73.01	45.9	47.95	29.51	25.35
Long-Term Investments	-	-	-	7.42	63.88	137.19
Other Long-Term Assets	8.95	8.31	4.06	4.72	4.92	3.12
Total Assets	535.54	688.14	669.34	355.6	416.76	476.77
Accounts Payable	12.21	11.22	11.48	6.4	5.06	6.65
Accrued Expenses	43.27	54.85	37.99	24.97	22.43	14.55
Current Portion of Leases	3.22	2.82	8.01	7.49	5.53	3.85
Unearned Revenue	13.32	17.58	38.36	48.1	37.63	41.21
Total Current Liabilities	72.02	86.47	95.85	86.96	70.66	66.26
Long-Term Leases	54.92	52.91	20.29	23.13	6.43	9.19
Other Long-Term Liabilities	5.97	10.01	26.21	45.02	35.97	59.02
Total Long-Term Liabilities	60.89	62.92	46.5	68.15	42.41	68.21
Total Liabilities	132.91	149.39	142.35	155.11	113.06	134.47
Common Stock	0.1	0.1	0.08	0.05	0.05	0.05
Additional Paid-in Capital	1,583	1,542	1,266	746.3	709.22	563.76
Accumulated Other Comprehensive Income	-0.15	0.11	0.15	-0.66	-4.32	-0.61
Retained Earnings	-1,180	-1,003	-738.77	-545.2	-401.25	-220.89
Shareholders' Equity	402.63	538.75	526.99	200.49	303.7	342.3
Total Liabilities & Equity	535.54	688.14	669.34	355.6	416.76	476.77
Total Debt	58.14	55.73	28.3	30.61	11.96	13.04
Net Cash (Debt)	385.39	537.21	581.28	257.29	297.18	282.68
Net Cash Growth	-28.26%	-7.58%	125.92%	-13.42%	5.13%	0.55%
Net Cash Per Share	3.85	6.20	8.66	4.74	6.11	6.59
Book Value	402.63	538.75	526.99	200.49	303.7	342.3
Book Value Per Share	4.02	6.22	7.85	3.69	6.25	7.98
Tangible Book Value	402.63	538.75	526.99	200.49	303.7	342.3
Tangible Book Value Per Share	4.02	6.22	7.85	3.69	6.25	7.98

SEC Filings: 10-K · 10-Q